Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Types02:20

Blood Types

Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HLA class II allele and haplotype frequencies in Koreans based on 107 families.

Tissue antigens·2002
Same author

Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation.

Bone marrow transplantation·2002
Same author

E variants found in Japanese and c antigenicity alteration without substitution in the second extracellular loop.

Transfusion·2001
Same author

Polymorphisms in the coding region of mtDNA and effects on clinical outcome of unrelated bone marrow transplantation.

Bone marrow transplantation·2001
Same author

The origin of Minnan and Hakka, the so-called "Taiwanese", inferred by HLA study.

Tissue antigens·2001
Same author

Allele frequency of HLA-B39 in the Japanese population and identification of a novel B39 allele, B*3923.

Tissue antigens·2001

Related Experiment Video

Updated: Jul 21, 2026

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
10:11

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

[HLA typing in the Japanese Bone Marrow Program]

T Akaza1

  • 1Japanese Red Cross Central Blood Center, Tokyo.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|February 1, 1997
PubMed
Summary

The Japan Marrow Donor Program (JMDP) uses a two-step HLA typing process to match donors and recipients. Initial typing includes HLA-A and HLA-B serology and low-resolution HLA-DRB1 DNA typing. Final matching involves reconfirming HLA-A and HLA-B and using high-resolution HLA-DRB1 DNA typing. Class I DNA typing is performed for A2, A26, B39, and B61, which are common in the Japanese population. A retrospective study of 363 transplants is evaluating how matching or mismatching HLA class I and class II alleles affects survival. The study suggests that matching HLA-A and HLA-B alleles reduces the risk of acute GVHD and improves survival in unrelated marrow transplants.

Keywords:
HLA typingbone marrow donortransplant immunologyacute GVHD

Frequently Asked Questions

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Related Experiment Videos

Last Updated: Jul 21, 2026

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model
10:11

Using Quantitative Real-time PCR to Determine Donor Cell Engraftment in a Competitive Murine Bone Marrow Transplantation Model

Published on: March 7, 2013

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Area of Science:

  • Transplant immunology
  • HLA typing methodologies
  • Bone marrow donor registries

Background:

Understanding compatibility between donors and recipients is essential in bone marrow transplantation. Prior research has shown that HLA matching influences transplant outcomes. However, the specific impact of high-resolution typing in certain populations remains unclear. The Japanese population exhibits unique HLA allele frequencies. These variations may affect transplant success rates. No prior work had resolved the role of class I and class II allele matching in this context. This gap motivated the JMDP to analyze their registry data. Their aim is to assess how allele-level matching affects survival and complications.

Purpose Of The Study:

The JMDP seeks to evaluate the impact of HLA allele matching on transplant outcomes. Specifically, the study focuses on the Japanese donor-recipient population. The goal is to determine how class I and class II allele matching affects survival. The researchers propose that precise matching reduces complications. They also aim to identify which alleles are most critical. This work addresses a knowledge gap in transplant immunology. The findings may inform donor selection strategies. The study uses a retrospective design with 363 transplants.

Main Methods:

The JMDP uses a two-step HLA typing process for donors. Initial typing includes serological HLA-A and HLA-B. Low-resolution HLA-DRB1 DNA typing is also performed. Final matching involves reconfirming HLA-A and HLA-B serologically. High-resolution HLA-DRB1 DNA typing is added for accuracy. Class I DNA typing targets A2, A26, B39, and B61. These alleles are common in the Japanese population. A retrospective analysis is being conducted on 363 transplants.

Main Results:

Matching HLA-A and HLA-B alleles reduced the risk of acute GVHD. This effect was observed in unrelated marrow transplants. Survival rates improved with better allele-level matching. The study found that high-resolution typing is important. Class I alleles A2, A26, B39, and B61 show significant variability. Each can be divided into more than three subtypes. The JMDP is analyzing how these subtypes affect outcomes. The Ministry of Health and Welfare supported this research.

Conclusions:

The JMDP study suggests that precise HLA allele matching improves transplant outcomes. Acute GVHD risk decreases with better class I matching. Survival rates also benefit from this approach. The study highlights the importance of high-resolution typing. Class I alleles A2, A26, B39, and B61 are particularly relevant. The JMDP is continuing its analysis of 363 transplants. These findings may guide donor selection in Japan. The Ministry of Health and Welfare endorses this research direction.

Matching HLA-A and HLA-B alleles reduced the risk of acute GVHD and improved survival in unrelated marrow transplants.

Class I DNA typing is performed for A2, A26, B39, and B61 due to their high frequency and multiple subtypes in the Japanese population.

High-resolution HLA-DRB1 DNA typing is used for final matching to ensure accurate donor-recipient compatibility.

The study aims to assess how matching or mismatching HLA class I and class II alleles affects survival rates.

Since 1992, about 82,000 donors and 4,400 patients have been registered in the JMDP.

The JMDP uses a two-step process: initial serological and low-resolution typing, followed by reconfirmation and high-resolution typing for final matching.